Fritextsökning
Innehållstyper
-
Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”
It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...
-
Remdesivir kan ges till fler patienter
Europeiska läkemedelsmyndigheten, EMA, har uppdaterat sin rekommendation för användning av remdesivir för svårt sjuka covid-19-patienter.
-
Upcoming event: New updates on drugs
At Medicon Valley Alliance venues in Copenhagen/Örestad April 1 2020 the meeting New updates in Drug Formulation & Bioavailability takes place for the for the eighth time.
-
Första resultaten för nygammalt läkemedel mot covid-19
I en ny studie förbättrades tillståndet för 68 procent av patienter med allvarlig covid-19 när de fick läkemedlet remdesivir. Men studien har flera svagheter oc...
-
Sweden and Denmark – this is how they choose their strategies
Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.
-
MVA:s CEO: “Our investments should improve people´s everyday lives”
Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.
-
Saving lives worldwide with low-cost molecular diagnostics
High throughput testing for many upper respiratory tract pathogens thanks to automation technology
-
Delivering drugs with small devices
There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...
-
Meet the governmental life science office
More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duti...
-
CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”
When the first CAR-T therapies appeared, hopes were raised for the effective treatment for critically ill cancer patients. After a somewhat sluggish start, abou...
-
Krönika: Can regulators keep up with innovation?
New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...
-
Column: "Are we already living in the new normal?"
2020 felt like the year that we were building the house around us whilst moving into it at the same time.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Drug development creates new challenges for regulators
-
Coordination of world-class research facilities
Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...
-
Omega-3 utreds
Nyligen publicerade studier antyder att omega-3-fettsyror inte skyddar mot hjärt-kärlsjuksjukdom hos personer som tidigare haft en hjärtinfarkt.
-
Microwave reactor for use in various synthesis applications
The Monowave 300 microwave reactor offers 850 watts of power for a variety of synthesis applications.
-
EU-godkända läkemedel - hela listan
Cancer, svälj- och luftrörsproblem och MS har fått nya behandlingar. EMA:s vetenskapliga kommitté har beslutat att följande läkemedel ska få säljas och marknadsföras inom EU.
-
”Sverige klarar tillverkningen”
I Matfors bygger Cobra Biologics två unika tillverkningssviter för storskalig GMP-tillverkning av ATMP-produkter. Kontraktstillverkaren rustar för att möta den ...
-
EMA-granskning efter dödsfall klar
Granskningen av MS-läkemedlet Zinbryta och myndighetens rekommendationer är klara.
-
One-step cleaning system for use in clean rooms
The Micronswep cleaning system from Berendsen is a single action cleaning system developed for use in clean rooms.
-
Dubbdäck tar fler liv än de räddar
Dubbarna river upp asfalt, vilket skördar fler liv än dubbarna räddar, enligt en ny studie inom ramen för programmet Mistra Environmental Nanosafety.
-
Pengaregn över hälsoprojekt
22 projekt inom läkemedel, medtech och e-hälsa delar på 20,5 miljoner i Vinnova-utlysning.
-
New diagnostic test soon ready for the market